Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Jeffrey Vacirca, MD, FACP
Chief Executive Officer
New York Cancer & Blood Specialists
Port Jefferson Station, NY
Authored Items
Granisetron Extended-Release Subcutaneous Injection versus Palonosetron Infusion for CINV Prevention: Cost Comparison of Unscheduled Hydration
Martin Barnes, MD
,
George Calcanes, BS, RN
,
Michael C. Mosier, PhD
,
Jeffrey Vacirca, MD, FACP
,
Zulfiqar Malik, MD, PhD
December 2021 Vol 14, No 4
in
Original Research
,
Practice Management
Last modified: September 17, 2021